Alpidem
Template:Wikify is deprecated. Please use a more specific cleanup template as listed in the documentation. |
This article needs attention from an expert on the subject. Please add a reason or a talk parameter to this template to explain the issue with the article. |
Alpidem is a prescription drug used for the treatment of moderate to severe anxiety. Alpidem, a fairly new drug, is not in wide use. In pure form, it is only available generically, but is an additional substance in a few prescription anxiolytic drugs. Alpidem acts selectively on the omega 1 (BZ1) receptor subtype, a benzodiazepine receptor. However, it is not considered of the benzodiazepine class, but is rather a imidazopyridine. Alpidem is a close relative of zolpidem, but does not possess zolpidem's sedative property.
Indications
Template:Totally-disputed-section
Alpidem is generally prescribed to patients with moderate to severe anxiety-who generally just want to get high, why, well...because it feels good I suppose, ask them.[original research?] Most of these patients have exhibited either sensitivity or resistance to benzodiazepine therapy, and therefore switched to a non-benzodiazepine medication. Alpidem does not produce significant, if any, sedative or hypnotic action. Alpidem is also used as an anticonvulsant at much higher doses.
See also
References and notes
- Zivkovic B, Morel E, Joly D, Perrault G, Sanger DJ, Lloyd KG.. "Pharmacological and behavioral profile of alpidem as an anxiolytic." Synthelabo Recherche, L.E.R.S., Bagneux, France. 1990 May;23 Suppl 3:108-13. PMID 1974069
- Sanger DJ, Zivkovic B.. "Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic." Synthelabo Recherche, Bagneux, France. 1994 Jan;113(3-4):395-403. PMID 7862851